Business

ACP Releases Policy Statement on DOI, COI Management for Clinical Guideline Development

The American College of Physicians endorses the necessity of a comprehensive process for disclosure of potential conflicts of interest to ensure the integrity of clinical guidelines and guidance statements.

Will Knowing the Cost of Medical Care Drive Down Prices?

The premise underlying the executive order signed by President Trump on June 24, 2019, is that if patients were informed about what hospitals and providers are charging for their services, then they would be able to shop around for better deals.

Investing Wisely in Cybersecurity

To make the best use of the money they have to spend to prevent information breaches, practices need to perform a risk analysis.

Medical School Debt Poses a Significant Burden for Most Physicians

Nearly two-thirds of actively practicing physicians are still carrying medical school debt, according to the Medical School Debt Report 2019.

Past Health Coverage Expansions Have Not Affected Rates of Hospital Use

Past coverage expansions were associated with little or no change in society-wide hospital use; increases in groups who gained coverage were offset by reductions among others.

Top Medical Organizations Call for Solutions to Reduce Firearm-Related Injury and Death

Individuals representing some of the nation’s preeminent medical organizations have called for “reasonable, evidence-based solutions” to reduce injury and death related to firearms.

Most Medicaid Beneficiaries in Kentucky Already Meet Community Engagement Requirements

Findings of this study suggest that most Medicaid beneficiaries who would be included in community engagement programs in Kentucky already meet activity requirements.

Policy Update: HHS Fetal Tissue Research Directive Raises Concerns

Some in the scientific community are concerned about the potential for less medical progress or possible delays of such after the latest policy changes regarding fetal tissue research in the United States.

Brand-Brand Competition Has Not Cut Prices in the US Pharmaceutical Market

Brand-brand competition in the U.S. pharmaceutical market has not lowered drug list prices.

Trump Administration Announces Plan to Allow Drug Imports From Canada

Americans could import less expensive prescription drugs from Canada under a plan being developed by the Trump administration.

The Link Between Misconceptions About Opioid Use Disorders and Current Policies

An estimated 20 million people in the United States meet the criteria for substance use disorder.

New Opioid Prescription Rules Coming for United States Employees’ Health Plans

Tighter rules on opioid painkiller prescriptions for U.S. government employees will be implemented in the fall.

ACO Investment Model Participation Associated With Lower Medicare Spending

Participation in Accountable Care Organization (ACO) Investment Model during the first performance year by providers serving rural/underserved areas was associated with lower spending in the Medicare program than that among non-ACO providers serving the same areas.

EAACI Position Paper on the Role of Mobile Heath in Allergy Management

A task force created by the European Academy of Allergy and Clinical Immunology released recommendations and an action plan for the potential of mobile health in allergology.

How Often Does the FDA Disagree With Its Advisory Committees’ Recommendations?

According to the findings of a recent review, the Food and Drug Administration rarely disagrees with recommendations made by its advisory committees.

Private Equity Stake Rising in Dermatology Practices

Private equity (PE) firms have a stake in an increasing number of dermatology practices throughout the United States.

Nonphysican Practitioners Filling Post-ACA Primary Care Gap

New Medicaid beneficiaries seeing nurse practitioners, physician assistants

Immigration Policy Stress and Health Outcomes in US-Born Latino Adolescents

Investigators assessed whether concerns about immigration policy are related to worse mental and physical health among US citizen children of Latino immigrants.

FDA Cracks Down on Company Selling CBD Products With Unapproved Therapeutic Claims

The Food and Drug Administration (FDA) has issued a warning letter to Curalef Inc. of Wakefield, Massachusetts for illegally selling unapproved cannabidiol (CBD) products online with unsubstantiated health claims.

AHA Recommendations for Neurologic Prognostication in Cardiac Arrest Survivors

A multidisciplinary writing group organized by the AHA Emergency Cardiovascular Care Science Subcommittee released recommendations to improve the quality of adult and pediatric neurologic prognostication studies for survivors of cardiac arrest.